Global Microbiomes Market Growth (Status and Outlook) 2025-2031

September 2025 | 157 pages | ID: G3D63B8DE8D3EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to this study, the global Microbiomes market size will reach US$ million by 2031.

United States market for Microbiomes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Microbiomes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Microbiomes is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Microbiomes players cover 4D Pharma, Enterome BioScience, Evelo Biosciences, Ferring, Osel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Microbiomes Industry Forecast” looks at past sales and reviews total world Microbiomes sales in 2024, providing a comprehensive analysis by region and market sector of projected Microbiomes sales for 2025 through 2031. With Microbiomes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microbiomes industry.

This Insight Report provides a comprehensive analysis of the global Microbiomes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Microbiomes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microbiomes market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microbiomes and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microbiomes.

This report presents a comprehensive overview, market shares, and growth opportunities of Microbiomes market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Gastrointestinal Microbiome
  • Genitourinary Microbiome
  • Skin Microbiome
  • Respiratory Microbiome
  • Other
Segmentation by Application:
  • Testing
  • Treatment
  • Diagnosis
  • Technology Platform
  • Probiotics
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • 4D Pharma
  • Enterome BioScience
  • Evelo Biosciences
  • Ferring
  • Osel
  • Second Genome
  • Seres Therapeutics
  • Synlogic
  • Synthetic Biologics and Vedanta Biosciences
  • Vedanta
  • Rebiotix
  • ActoGeniX
  • Enterologics
  • Metabogen
  • Metabiomics
  • Ritter Pharmaceuticals
  • AvidBiotics
  • Symberix
  • Miomics
  • Symbiotix Biotherapies
  • MicroBiome Therapeutics LLC
  • SciBac Inc
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Microbiomes Market Size (2020-2031)
  2.1.2 Microbiomes Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Microbiomes by Country/Region (2020, 2024 & 2031)
2.2 Microbiomes Segment by Type
  2.2.1 Gastrointestinal Microbiome
  2.2.2 Genitourinary Microbiome
  2.2.3 Skin Microbiome
  2.2.4 Respiratory Microbiome
  2.2.5 Other
2.3 Microbiomes Market Size by Type
  2.3.1 Microbiomes Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Microbiomes Market Size Market Share by Type (2020-2025)
2.4 Microbiomes Segment by Application
  2.4.1 Testing
  2.4.2 Treatment
  2.4.3 Diagnosis
  2.4.4 Technology Platform
  2.4.5 Probiotics
  2.4.6 Other
2.5 Microbiomes Market Size by Application
  2.5.1 Microbiomes Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Microbiomes Market Size Market Share by Application (2020-2025)

3 MICROBIOMES MARKET SIZE BY PLAYER

3.1 Microbiomes Market Size Market Share by Player
  3.1.1 Global Microbiomes Revenue by Player (2020-2025)
  3.1.2 Global Microbiomes Revenue Market Share by Player (2020-2025)
3.2 Global Microbiomes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MICROBIOMES BY REGION

4.1 Microbiomes Market Size by Region (2020-2025)
4.2 Global Microbiomes Annual Revenue by Country/Region (2020-2025)
4.3 Americas Microbiomes Market Size Growth (2020-2025)
4.4 APAC Microbiomes Market Size Growth (2020-2025)
4.5 Europe Microbiomes Market Size Growth (2020-2025)
4.6 Middle East & Africa Microbiomes Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Microbiomes Market Size by Country (2020-2025)
5.2 Americas Microbiomes Market Size by Type (2020-2025)
5.3 Americas Microbiomes Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Microbiomes Market Size by Region (2020-2025)
6.2 APAC Microbiomes Market Size by Type (2020-2025)
6.3 APAC Microbiomes Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Microbiomes Market Size by Country (2020-2025)
7.2 Europe Microbiomes Market Size by Type (2020-2025)
7.3 Europe Microbiomes Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Microbiomes by Region (2020-2025)
8.2 Middle East & Africa Microbiomes Market Size by Type (2020-2025)
8.3 Middle East & Africa Microbiomes Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MICROBIOMES MARKET FORECAST

10.1 Global Microbiomes Forecast by Region (2026-2031)
  10.1.1 Global Microbiomes Forecast by Region (2026-2031)
  10.1.2 Americas Microbiomes Forecast
  10.1.3 APAC Microbiomes Forecast
  10.1.4 Europe Microbiomes Forecast
  10.1.5 Middle East & Africa Microbiomes Forecast
10.2 Americas Microbiomes Forecast by Country (2026-2031)
  10.2.1 United States Market Microbiomes Forecast
  10.2.2 Canada Market Microbiomes Forecast
  10.2.3 Mexico Market Microbiomes Forecast
  10.2.4 Brazil Market Microbiomes Forecast
10.3 APAC Microbiomes Forecast by Region (2026-2031)
  10.3.1 China Microbiomes Market Forecast
  10.3.2 Japan Market Microbiomes Forecast
  10.3.3 Korea Market Microbiomes Forecast
  10.3.4 Southeast Asia Market Microbiomes Forecast
  10.3.5 India Market Microbiomes Forecast
  10.3.6 Australia Market Microbiomes Forecast
10.4 Europe Microbiomes Forecast by Country (2026-2031)
  10.4.1 Germany Market Microbiomes Forecast
  10.4.2 France Market Microbiomes Forecast
  10.4.3 UK Market Microbiomes Forecast
  10.4.4 Italy Market Microbiomes Forecast
  10.4.5 Russia Market Microbiomes Forecast
10.5 Middle East & Africa Microbiomes Forecast by Region (2026-2031)
  10.5.1 Egypt Market Microbiomes Forecast
  10.5.2 South Africa Market Microbiomes Forecast
  10.5.3 Israel Market Microbiomes Forecast
  10.5.4 Turkey Market Microbiomes Forecast
10.6 Global Microbiomes Forecast by Type (2026-2031)
10.7 Global Microbiomes Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Microbiomes Forecast

11 KEY PLAYERS ANALYSIS

11.1 4D Pharma
  11.1.1 4D Pharma Company Information
  11.1.2 4D Pharma Microbiomes Product Offered
  11.1.3 4D Pharma Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 4D Pharma Main Business Overview
  11.1.5 4D Pharma Latest Developments
11.2 Enterome BioScience
  11.2.1 Enterome BioScience Company Information
  11.2.2 Enterome BioScience Microbiomes Product Offered
  11.2.3 Enterome BioScience Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Enterome BioScience Main Business Overview
  11.2.5 Enterome BioScience Latest Developments
11.3 Evelo Biosciences
  11.3.1 Evelo Biosciences Company Information
  11.3.2 Evelo Biosciences Microbiomes Product Offered
  11.3.3 Evelo Biosciences Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Evelo Biosciences Main Business Overview
  11.3.5 Evelo Biosciences Latest Developments
11.4 Ferring
  11.4.1 Ferring Company Information
  11.4.2 Ferring Microbiomes Product Offered
  11.4.3 Ferring Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Ferring Main Business Overview
  11.4.5 Ferring Latest Developments
11.5 Osel
  11.5.1 Osel Company Information
  11.5.2 Osel Microbiomes Product Offered
  11.5.3 Osel Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Osel Main Business Overview
  11.5.5 Osel Latest Developments
11.6 Second Genome
  11.6.1 Second Genome Company Information
  11.6.2 Second Genome Microbiomes Product Offered
  11.6.3 Second Genome Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Second Genome Main Business Overview
  11.6.5 Second Genome Latest Developments
11.7 Seres Therapeutics
  11.7.1 Seres Therapeutics Company Information
  11.7.2 Seres Therapeutics Microbiomes Product Offered
  11.7.3 Seres Therapeutics Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Seres Therapeutics Main Business Overview
  11.7.5 Seres Therapeutics Latest Developments
11.8 Synlogic
  11.8.1 Synlogic Company Information
  11.8.2 Synlogic Microbiomes Product Offered
  11.8.3 Synlogic Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Synlogic Main Business Overview
  11.8.5 Synlogic Latest Developments
11.9 Synthetic Biologics and Vedanta Biosciences
  11.9.1 Synthetic Biologics and Vedanta Biosciences Company Information
  11.9.2 Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offered
  11.9.3 Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Synthetic Biologics and Vedanta Biosciences Main Business Overview
  11.9.5 Synthetic Biologics and Vedanta Biosciences Latest Developments
11.10 Vedanta
  11.10.1 Vedanta Company Information
  11.10.2 Vedanta Microbiomes Product Offered
  11.10.3 Vedanta Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Vedanta Main Business Overview
  11.10.5 Vedanta Latest Developments
11.11 Rebiotix
  11.11.1 Rebiotix Company Information
  11.11.2 Rebiotix Microbiomes Product Offered
  11.11.3 Rebiotix Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Rebiotix Main Business Overview
  11.11.5 Rebiotix Latest Developments
11.12 ActoGeniX
  11.12.1 ActoGeniX Company Information
  11.12.2 ActoGeniX Microbiomes Product Offered
  11.12.3 ActoGeniX Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 ActoGeniX Main Business Overview
  11.12.5 ActoGeniX Latest Developments
11.13 Enterologics
  11.13.1 Enterologics Company Information
  11.13.2 Enterologics Microbiomes Product Offered
  11.13.3 Enterologics Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.13.4 Enterologics Main Business Overview
  11.13.5 Enterologics Latest Developments
11.14 Metabogen
  11.14.1 Metabogen Company Information
  11.14.2 Metabogen Microbiomes Product Offered
  11.14.3 Metabogen Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.14.4 Metabogen Main Business Overview
  11.14.5 Metabogen Latest Developments
11.15 Metabiomics
  11.15.1 Metabiomics Company Information
  11.15.2 Metabiomics Microbiomes Product Offered
  11.15.3 Metabiomics Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.15.4 Metabiomics Main Business Overview
  11.15.5 Metabiomics Latest Developments
11.16 Ritter Pharmaceuticals
  11.16.1 Ritter Pharmaceuticals Company Information
  11.16.2 Ritter Pharmaceuticals Microbiomes Product Offered
  11.16.3 Ritter Pharmaceuticals Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.16.4 Ritter Pharmaceuticals Main Business Overview
  11.16.5 Ritter Pharmaceuticals Latest Developments
11.17 AvidBiotics
  11.17.1 AvidBiotics Company Information
  11.17.2 AvidBiotics Microbiomes Product Offered
  11.17.3 AvidBiotics Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.17.4 AvidBiotics Main Business Overview
  11.17.5 AvidBiotics Latest Developments
11.18 Symberix
  11.18.1 Symberix Company Information
  11.18.2 Symberix Microbiomes Product Offered
  11.18.3 Symberix Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.18.4 Symberix Main Business Overview
  11.18.5 Symberix Latest Developments
11.19 Miomics
  11.19.1 Miomics Company Information
  11.19.2 Miomics Microbiomes Product Offered
  11.19.3 Miomics Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.19.4 Miomics Main Business Overview
  11.19.5 Miomics Latest Developments
11.20 Symbiotix Biotherapies
  11.20.1 Symbiotix Biotherapies Company Information
  11.20.2 Symbiotix Biotherapies Microbiomes Product Offered
  11.20.3 Symbiotix Biotherapies Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.20.4 Symbiotix Biotherapies Main Business Overview
  11.20.5 Symbiotix Biotherapies Latest Developments
11.21 MicroBiome Therapeutics LLC
  11.21.1 MicroBiome Therapeutics LLC Company Information
  11.21.2 MicroBiome Therapeutics LLC Microbiomes Product Offered
  11.21.3 MicroBiome Therapeutics LLC Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.21.4 MicroBiome Therapeutics LLC Main Business Overview
  11.21.5 MicroBiome Therapeutics LLC Latest Developments
11.22 SciBac Inc
  11.22.1 SciBac Inc Company Information
  11.22.2 SciBac Inc Microbiomes Product Offered
  11.22.3 SciBac Inc Microbiomes Revenue, Gross Margin and Market Share (2020-2025)
  11.22.4 SciBac Inc Main Business Overview
  11.22.5 SciBac Inc Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Microbiomes Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Microbiomes Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gastrointestinal Microbiome
Table 4. Major Players of Genitourinary Microbiome
Table 5. Major Players of Skin Microbiome
Table 6. Major Players of Respiratory Microbiome
Table 7. Major Players of Other
Table 8. Microbiomes Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Microbiomes Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Microbiomes Market Size Market Share by Type (2020-2025)
Table 11. Microbiomes Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Microbiomes Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Microbiomes Market Size Market Share by Application (2020-2025)
Table 14. Global Microbiomes Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Microbiomes Revenue Market Share by Player (2020-2025)
Table 16. Microbiomes Key Players Head office and Products Offered
Table 17. Microbiomes Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Microbiomes Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Microbiomes Market Size Market Share by Region (2020-2025)
Table 22. Global Microbiomes Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Microbiomes Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Microbiomes Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Microbiomes Market Size Market Share by Country (2020-2025)
Table 26. Americas Microbiomes Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Microbiomes Market Size Market Share by Type (2020-2025)
Table 28. Americas Microbiomes Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Microbiomes Market Size Market Share by Application (2020-2025)
Table 30. APAC Microbiomes Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Microbiomes Market Size Market Share by Region (2020-2025)
Table 32. APAC Microbiomes Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Microbiomes Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Microbiomes Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Microbiomes Market Size Market Share by Country (2020-2025)
Table 36. Europe Microbiomes Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Microbiomes Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Microbiomes Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Microbiomes Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Microbiomes Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Microbiomes
Table 42. Key Market Challenges & Risks of Microbiomes
Table 43. Key Industry Trends of Microbiomes
Table 44. Global Microbiomes Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Microbiomes Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Microbiomes Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Microbiomes Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. 4D Pharma Details, Company Type, Microbiomes Area Served and Its Competitors
Table 49. 4D Pharma Microbiomes Product Offered
Table 50. 4D Pharma Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. 4D Pharma Main Business
Table 52. 4D Pharma Latest Developments
Table 53. Enterome BioScience Details, Company Type, Microbiomes Area Served and Its Competitors
Table 54. Enterome BioScience Microbiomes Product Offered
Table 55. Enterome BioScience Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Enterome BioScience Main Business
Table 57. Enterome BioScience Latest Developments
Table 58. Evelo Biosciences Details, Company Type, Microbiomes Area Served and Its Competitors
Table 59. Evelo Biosciences Microbiomes Product Offered
Table 60. Evelo Biosciences Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Evelo Biosciences Main Business
Table 62. Evelo Biosciences Latest Developments
Table 63. Ferring Details, Company Type, Microbiomes Area Served and Its Competitors
Table 64. Ferring Microbiomes Product Offered
Table 65. Ferring Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Ferring Main Business
Table 67. Ferring Latest Developments
Table 68. Osel Details, Company Type, Microbiomes Area Served and Its Competitors
Table 69. Osel Microbiomes Product Offered
Table 70. Osel Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Osel Main Business
Table 72. Osel Latest Developments
Table 73. Second Genome Details, Company Type, Microbiomes Area Served and Its Competitors
Table 74. Second Genome Microbiomes Product Offered
Table 75. Second Genome Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Second Genome Main Business
Table 77. Second Genome Latest Developments
Table 78. Seres Therapeutics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 79. Seres Therapeutics Microbiomes Product Offered
Table 80. Seres Therapeutics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Seres Therapeutics Main Business
Table 82. Seres Therapeutics Latest Developments
Table 83. Synlogic Details, Company Type, Microbiomes Area Served and Its Competitors
Table 84. Synlogic Microbiomes Product Offered
Table 85. Synlogic Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Synlogic Main Business
Table 87. Synlogic Latest Developments
Table 88. Synthetic Biologics and Vedanta Biosciences Details, Company Type, Microbiomes Area Served and Its Competitors
Table 89. Synthetic Biologics and Vedanta Biosciences Microbiomes Product Offered
Table 90. Synthetic Biologics and Vedanta Biosciences Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. Synthetic Biologics and Vedanta Biosciences Main Business
Table 92. Synthetic Biologics and Vedanta Biosciences Latest Developments
Table 93. Vedanta Details, Company Type, Microbiomes Area Served and Its Competitors
Table 94. Vedanta Microbiomes Product Offered
Table 95. Vedanta Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Vedanta Main Business
Table 97. Vedanta Latest Developments
Table 98. Rebiotix Details, Company Type, Microbiomes Area Served and Its Competitors
Table 99. Rebiotix Microbiomes Product Offered
Table 100. Rebiotix Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Rebiotix Main Business
Table 102. Rebiotix Latest Developments
Table 103. ActoGeniX Details, Company Type, Microbiomes Area Served and Its Competitors
Table 104. ActoGeniX Microbiomes Product Offered
Table 105. ActoGeniX Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. ActoGeniX Main Business
Table 107. ActoGeniX Latest Developments
Table 108. Enterologics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 109. Enterologics Microbiomes Product Offered
Table 110. Enterologics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 111. Enterologics Main Business
Table 112. Enterologics Latest Developments
Table 113. Metabogen Details, Company Type, Microbiomes Area Served and Its Competitors
Table 114. Metabogen Microbiomes Product Offered
Table 115. Metabogen Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 116. Metabogen Main Business
Table 117. Metabogen Latest Developments
Table 118. Metabiomics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 119. Metabiomics Microbiomes Product Offered
Table 120. Metabiomics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 121. Metabiomics Main Business
Table 122. Metabiomics Latest Developments
Table 123. Ritter Pharmaceuticals Details, Company Type, Microbiomes Area Served and Its Competitors
Table 124. Ritter Pharmaceuticals Microbiomes Product Offered
Table 125. Ritter Pharmaceuticals Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 126. Ritter Pharmaceuticals Main Business
Table 127. Ritter Pharmaceuticals Latest Developments
Table 128. AvidBiotics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 129. AvidBiotics Microbiomes Product Offered
Table 130. AvidBiotics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 131. AvidBiotics Main Business
Table 132. AvidBiotics Latest Developments
Table 133. Symberix Details, Company Type, Microbiomes Area Served and Its Competitors
Table 134. Symberix Microbiomes Product Offered
Table 135. Symberix Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 136. Symberix Main Business
Table 137. Symberix Latest Developments
Table 138. Miomics Details, Company Type, Microbiomes Area Served and Its Competitors
Table 139. Miomics Microbiomes Product Offered
Table 140. Miomics Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 141. Miomics Main Business
Table 142. Miomics Latest Developments
Table 143. Symbiotix Biotherapies Details, Company Type, Microbiomes Area Served and Its Competitors
Table 144. Symbiotix Biotherapies Microbiomes Product Offered
Table 145. Symbiotix Biotherapies Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 146. Symbiotix Biotherapies Main Business
Table 147. Symbiotix Biotherapies Latest Developments
Table 148. MicroBiome Therapeutics LLC Details, Company Type, Microbiomes Area Served and Its Competitors
Table 149. MicroBiome Therapeutics LLC Microbiomes Product Offered
Table 150. MicroBiome Therapeutics LLC Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 151. MicroBiome Therapeutics LLC Main Business
Table 152. MicroBiome Therapeutics LLC Latest Developments
Table 153. SciBac Inc Details, Company Type, Microbiomes Area Served and Its Competitors
Table 154. SciBac Inc Microbiomes Product Offered
Table 155. SciBac Inc Microbiomes Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 156. SciBac Inc Main Business
Table 157. SciBac Inc Latest Developments

LIST OF FIGURES

Figure 1. Microbiomes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Microbiomes Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Microbiomes Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Microbiomes Sales Market Share by Country/Region (2024)
Figure 8. Microbiomes Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Microbiomes Market Size Market Share by Type in 2024
Figure 10. Microbiomes in Testing
Figure 11. Global Microbiomes Market: Testing (2020-2025) & ($ millions)
Figure 12. Microbiomes in Treatment
Figure 13. Global Microbiomes Market: Treatment (2020-2025) & ($ millions)
Figure 14. Microbiomes in Diagnosis
Figure 15. Global Microbiomes Market: Diagnosis (2020-2025) & ($ millions)
Figure 16. Microbiomes in Technology Platform
Figure 17. Global Microbiomes Market: Technology Platform (2020-2025) & ($ millions)
Figure 18. Microbiomes in Probiotics
Figure 19. Global Microbiomes Market: Probiotics (2020-2025) & ($ millions)
Figure 20. Microbiomes in Other
Figure 21. Global Microbiomes Market: Other (2020-2025) & ($ millions)
Figure 22. Global Microbiomes Market Size Market Share by Application in 2024
Figure 23. Global Microbiomes Revenue Market Share by Player in 2024
Figure 24. Global Microbiomes Market Size Market Share by Region (2020-2025)
Figure 25. Americas Microbiomes Market Size 2020-2025 ($ millions)
Figure 26. APAC Microbiomes Market Size 2020-2025 ($ millions)
Figure 27. Europe Microbiomes Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Microbiomes Market Size 2020-2025 ($ millions)
Figure 29. Americas Microbiomes Value Market Share by Country in 2024
Figure 30. United States Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Microbiomes Market Size Market Share by Region in 2024
Figure 35. APAC Microbiomes Market Size Market Share by Type (2020-2025)
Figure 36. APAC Microbiomes Market Size Market Share by Application (2020-2025)
Figure 37. China Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 41. India Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Microbiomes Market Size Market Share by Country in 2024
Figure 44. Europe Microbiomes Market Size Market Share by Type (2020-2025)
Figure 45. Europe Microbiomes Market Size Market Share by Application (2020-2025)
Figure 46. Germany Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 47. France Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Microbiomes Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Microbiomes Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Microbiomes Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Microbiomes Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Microbiomes Market Size 2026-2031 ($ millions)
Figure 60. APAC Microbiomes Market Size 2026-2031 ($ millions)
Figure 61. Europe Microbiomes Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Microbiomes Market Size 2026-2031 ($ millions)
Figure 63. United States Microbiomes Market Size 2026-2031 ($ millions)
Figure 64. Canada Microbiomes Market Size 2026-2031 ($ millions)
Figure 65. Mexico Microbiomes Market Size 2026-2031 ($ millions)
Figure 66. Brazil Microbiomes Market Size 2026-2031 ($ millions)
Figure 67. China Microbiomes Market Size 2026-2031 ($ millions)
Figure 68. Japan Microbiomes Market Size 2026-2031 ($ millions)
Figure 69. Korea Microbiomes Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Microbiomes Market Size 2026-2031 ($ millions)
Figure 71. India Microbiomes Market Size 2026-2031 ($ millions)
Figure 72. Australia Microbiomes Market Size 2026-2031 ($ millions)
Figure 73. Germany Microbiomes Market Size 2026-2031 ($ millions)
Figure 74. France Microbiomes Market Size 2026-2031 ($ millions)
Figure 75. UK Microbiomes Market Size 2026-2031 ($ millions)
Figure 76. Italy Microbiomes Market Size 2026-2031 ($ millions)
Figure 77. Russia Microbiomes Market Size 2026-2031 ($ millions)
Figure 78. Egypt Microbiomes Market Size 2026-2031 ($ millions)
Figure 79. South Africa Microbiomes Market Size 2026-2031 ($ millions)
Figure 80. Israel Microbiomes Market Size 2026-2031 ($ millions)
Figure 81. Turkey Microbiomes Market Size 2026-2031 ($ millions)
Figure 82. Global Microbiomes Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Microbiomes Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Microbiomes Market Size 2026-2031 ($ millions)